These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23906502)

  • 41. Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature.
    Abougergi MS; Broor A; Cui W; Jaar BG
    J Hosp Med; 2010 Jan; 5(1):E1-9. PubMed ID: 20063275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Severe and resistant cutaneous involvement in dermatomyositis: value of intravenous immunoglobulins].
    Castanet J; Lacour JP; Ortonne JP
    Rev Med Interne; 1993; 14(7):737. PubMed ID: 8191078
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
    Deakin CT; Campanilho-Marques R; Simou S; Moraitis E; Wedderburn LR; Pullenayegum E; Pilkington CA;
    Arthritis Rheumatol; 2018 May; 70(5):785-793. PubMed ID: 29342499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
    Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
    J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
    Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
    Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
    Stoll T; Michel BA; Neidhart M; Wassmer P; Neidl K; Fehr K; Wagenhäuser FJ
    Schweiz Med Wochenschr; 1992 Sep; 122(39):1458-65. PubMed ID: 1411405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective, noncomparative open study from Kuwait of the role of intravenous immunoglobulin in the treatment of toxic epidermal necrolysis.
    Al-Mutairi N; Arun J; Osama NE; Amr Z; Mazen AS; Ibtesam el-A; Nazeha el-B
    Int J Dermatol; 2004 Nov; 43(11):847-51. PubMed ID: 15533072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
    Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
    Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.
    Yip LW; Thong BY; Tan AW; Khin LW; Chng HH; Heng WJ
    Eye (Lond); 2005 Aug; 19(8):846-53. PubMed ID: 15389280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of intravenous immunoglobulins (IVIg) in improving skin symptoms in patients with dermatomyositis: a post-hoc analysis of the ProDERM study.
    Werth VP; Aggarwal R; Charles-Schoeman C; Schessl J; Levine T; Kopasz N; Worm M; Bata-Csörgő Z
    EClinicalMedicine; 2023 Oct; 64():102234. PubMed ID: 37799613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
    Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
    Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe and refractory solar urticaria treated with intravenous immunoglobulins: a phase II multicenter study.
    Aubin F; Porcher R; Jeanmougin M; Léonard F; Bedane C; Moreau A; Schmutz JL; Marguery MC; Adamski H; Viguier M;
    J Am Acad Dermatol; 2014 Nov; 71(5):948-953.e1. PubMed ID: 25135650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin.
    Amemiya K; Semino-Mora C; Granger RP; Dalakas MC
    Clin Immunol; 2000 Feb; 94(2):99-104. PubMed ID: 10637094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of pyoderma gangrenosum with intravenous immunoglobulin.
    Cummins DL; Anhalt GJ; Monahan T; Meyerle JH
    Br J Dermatol; 2007 Dec; 157(6):1235-9. PubMed ID: 17916196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of low-dose methotrexate in the treatment of dermatomyositis skin lesions.
    Hornung T; Ko A; Tüting T; Bieber T; Wenzel J
    Clin Exp Dermatol; 2012 Mar; 37(2):139-42. PubMed ID: 21981743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
    Dalakas MC; Illa I; Dambrosia JM; Soueidan SA; Stein DP; Otero C; Dinsmore ST; McCrosky S
    N Engl J Med; 1993 Dec; 329(27):1993-2000. PubMed ID: 8247075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.